FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 400 ug/5 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-010 | 71506-010-58 | Phenylephrine Hydrochloride | 10 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-099 | 71506-099-05 | Rocuronium Bromide | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-034 | 71506-034-05 | Succinylcholine Chloride | 100 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | 500 mg/100 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 750 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2 g/500 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | 1 g/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 15 mg/3 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-060 | 71506-060-58 | Epinephrine | 8 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-035 | 71506-035-56 | Acyclovir Sodium | 200 mg/100 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-023 | 71506-023-03 | Glycopyrrolate | .6 mg/3 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 1000 mg/100 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 20 mg/4 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 100 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 080570297 | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 100 mg/10 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | .5 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-125 | 63037-125-25 | Glycopyrrolate | 1 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-162 | 63037-162-25 | Lidocaine Hydrochloride Anhydrous | 50 mg/5 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2500 ug/250 mL | 2023-2 | valid | 2026-11-08 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-100 | 63037-100-05 | Fentanyl Citrate | 1000 ug/100 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5222 | 26436-5222-2 | "2,3-Dimercaptosuccinic Acid" | 250 mg | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5558 | 26436-5558-5 | Nadide | 50 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5558 | 26436-5558-0 | Nadide | 50 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-6026 | 26436-6026-1 | Nadide | 200 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5556 | 26436-5556-1 | Naltrexone | 4.5 mg | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5197 | 26436-5197-1 | Naltrexone | 3 mg | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-0724 | 26436-0724-9 | Naltrexone | 2 mg | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 200 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5066 | 26436-5066-3 | Niacinamide | 100 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-6 | Nystatin | 100000 U/1 g | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-3 | Nystatin | 100000 U/1 g | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-1115 | 26436-1115-1 | Oxandrolone | 25 mg | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5007 | 26436-5007-3 | Panthenol | 250 mg/1 mL | 2023-2 | valid | 2026-11-08 |